Soleus Capital Management »

Lb Pharmaceuticals shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Lb Pharmaceuticals shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.3M 400k 15.79

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Tg Therapeutics (TGTX)
Novocure Ord Shs (NVCR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Anthem (ELV)
Beta Bionics (BBNX)
United Therapeutics Corporation (UTHR)
Terns Pharmaceuticals (TERN)
Celcuity (CELC)
Inspire Med Sys (INSP)
Twist Bioscience Corp (TWST)
Argenx Se Sponsored Adr (ARGX)
Organogenesis Hldgs (ORGO)
BioMarin Pharmaceutical (BMRN)
Cidara Therapeutics Com New (CDTX)

View all positions for Soleus Capital Management

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Vivo Capital
Jennison Associates
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management
Soleus Capital Management

View all funds holding Lb Pharmaceuticals